Preliminary Program: Monday, May 16
7 a.m.-8:30 a.m.
New Research Young Investigator Poster Session 5
Scientific and Clinical Report
SCR19. Historical and Research Issues
63. The Participation of German Physicians in the So-Called "Euthanasia Program" During the Third Reich: Motivations, Verdicts, and Sentences Robert McKelvey, M.D.
64. Development of a Comorbidity Index for Mental Health Dianne Groll, Ph.D.
65. Dreaming With Jung: Carl Jung's Red Book and Critical Implications for Psychiatric Practice 90 Years Later Scott Simpson, M.D., M.P.H.
66. Risks of Readmission in Patients Diagnosed With Bipolar, Major Depressive, or Schizoaffective Disorders: A Longitudinal Study Stephen Woolley, D.Sc., M.P.H.
Workshops
W51. Charting the Next Frontier in Psychiatry: The Applications, Barriers, and Impact of Telepsychiatry on Mental Health Care Chairs: Sonya Lazarevic, M.D., M.S.W., Steven E. Hyler, M.D.
W52. Approaching Attention-Deficit Disorder in University Populations: Dosing, Diagnosing (and Detecting Those Just Looking for a Buzz) Chairs: Gordon D. Strauss, M.D., Beverly Fauman, M.D.
W53. Psychiatry at a Crossroads: Our Changing Role in the House of Medicine APA Council on Psychosomatic Medicine and Geriatric Psychiatry; Chair: Christopher W. Tjoa, M.D., B.S.
W54. Motivational Therapy for Individuals With Concurrent Disorders Chair: Shimi Kang, M.D.
W55. Making the Most of Your Chief Year: Chief Residents' Forum I Chair: Jonathan Amiel, M.D. (Open to residents only)
W56. Patient Suicide During Psychiatry Residency: A Workshop Discussion Chairs: Meredith A. Kelly, M.D., Emily Gastelum, M.D.
W57. Collateral Damage: Teaching Residents About the Impact of Patient Suicide Chairs: Joan M. Anzia, M.D., Glen O. Gabbard, M.D.
W58. Dynamic Therapy With Self-Destructive Borderlines: An Alliance-Based Intervention for Suicide Chair: Eric M. Plakun, M.D.
7 a.m.-11 a.m.
Courses 18-24
Seminar
SM8. Evidence-Based Psychodynamic Therapy Chairs: Richard F. Summers, M.D., Jacques P. Barber, Ph.D.
7 a.m.-2 p.m.
Courses 25-29
Master Course
MC04. Assessment and Treatment of Bipolar Disorder Chairs: Terence A. Ketter, M.D., Po W. Wang, M.D.
8 a.m.-9:30 a.m.
Case Conference
CC2. Linking Medicine and Psychiatry: Clinical Cases in Psychosomatic Medicine Chair: Michelle B. Riba, M.D., M.S.
Focus Live 1
Treatment-Resistant Disorders Chair: Charles B. Nemeroff, M.D.,
Forum
F3. DSM-5: Research and Development Chairs: David J. Kupfer, M.D., Darrel A. Regier, M.D.
Lectures
L11. Wrongful Convictions: Challenges for Psychiatry and Forensic Science Chair: Barry Scheck, J.D.
L12. Distinguished Psychiatrist Lecture National Institute of Mental Health; Chair: David Lewis, M.D.
L13. Judd Marmor Award Lecture Chair: Lawrence Siever, M.D.
Small Interactive Sessions
SI04. Opportunities in the Addiction Field: What You Should Know About Treatment, Training, and Research Chair: Marc Galanter, M.D. (Open to residents only)
SI05. Patients With Personality Disorders Chair: John M. Oldham, M.D., M.S. (Open to residents only)
Workshops
W59. The War: Understanding and Confronting Scientology's Efforts to Destroy Psychiatry Chair: Stephen R. Wiseman, M.D.
W60. High-Yield Cognitive-Behavioral Therapy for Brief Sessions Chair: Jesse H. Wright, M.D., Ph.D.
8 a.m.-11 a.m.
Advances in Research
AR1. Advances in Research Chair: Herbert Pardes, M.D.
Anxiety Disorder in Children and Adolescents: State-of-the-Art Assessment and Treatment John Walkup, M.D.
Posttraumatic Stress Disorder, Major Depression, and the Risk for Suicidal Behavior Maria Oquendo, M.D.
Successful Cognitive Aging and Wisdom Dilip V. Jeste, M.D.
Depression and Diabetes: Unhealthy Bedfellows Wayne Katon, M.D.
Media Workshop
MW5. Psychotherapeutic Augmentation of Medication Checks Using Functional Analytic Psychotherapy (FAP) Chairs: Grant Miller, M.D., Barbara Kohlenberg, Ph.D.
Presidential Symposium
PS3. Psychiatry and Primary Care Collaboration Under Health Care Reform: Sustainable Models That Improve Access and Quality Chair: Henry Chung, M.D.
Collaborative Care for College Students: The National College Depression Partnership (NCDP) Henry Chung, M.D.
Health Plan Implementation of Primary Care–Based Behavioral Health Services Hyong Un, M.D.
Improving Mental Health Care for Medical Outpatients: A Co-Location Model Using Psychiatrists in Urban Primary Care Settings Bruce Schwartz, M.D.
Improving Medical Care of Patients Receiving Behavioral Health Care Joseph Parks, M.D.
Achieving Comprehensive, Sustainable Models of Care in the Patient-Centered Medical Home Under Health Care Reform Frank Degruy, M.D.
Symposia
S34. Updates on Psychological Impacts of the Wars in Afghanistan and Iraq: Best Modalities of Screening and Treatment
Managing the Effects of Combat Trauma: The Evolving Practice at Walter Reed Army Medical Center John Bradley, M.D.
Managing the Effects of Combat Trauma: The Evolving Practice at Walter Reed Army Medical Center Scott Moran, M.D.
The Pacific Psychological Health Task Force: Enhancing Treatment Through Establishment of Partnerships in the Pacific Region Carroll Diebold, M.D.
Pharmacotherapy for PTSD in Combat Veterans: Challenges and Opportunities David Benedek, M.D.
Building DoD/VA/State and Community Partnership in Service to OEF/OIF Veterans and Their Families: Military Culture and Community Competence Harold Kudler, M.D.
S35. Teaching What Every Psychiatrist Needs to Know About Neuroscience
Teaching Neuroscience to Psychiatry Residents: What to Teach and How to Teach It Mayada Akil, M.D.
Integrating Neuroscience in the Training of Psychiatrists: The Yale Experience David Ross, M.D., Ph.D.
Organizing a Neuroscience Course Around the Research Domain Criteria Project (RDoC) Amit Etkin, M.D., Ph.D.
S36. The Shrinking Psychotherapeutic Pipeline: Why Has the Spigot Been Turned Off?
Increasing the Validity of Animal Models of Depression by Genetic-Environment Interactions Irwin Lucki, Ph.D.
New Drugs to No Drugs: Antidepressants and Drug Discovery/Development David Michelson, M.D.
Cross-Species Tests for Cognition Enhancement in Schizophrenia Mark Geyer, Ph.D.
Alzheimer's Disease Clinical Trial Failures: Ineffective Drugs or Flawed Clinical Trials? Nigel Greig, Ph.D.
S37. Is Whole Person Psychiatry Possible?
Whole Person Care in Psychiatry and in Palliative Medicine John Peteet, M.D.
Clinical Implications of Research on Healthy Personality Functioning C. Robert Cloninger, M.D.
Patient Preferences and Values: The Connecting Thread Between Evidence-Based Medicine and Cultural Competence Francis Lu, M.D.
Spirituality and Health: Guidelines for Clinical Care and Curriculum Development Christina Puchalski, M.D.
Comprehensive Treatment of Complex Patients: The Psychiatrist's Role Nadine Nyhus, M.D., M.A.
S38. Integrating Couples and Family Treatment Into Patient Care
How to Do a Biopsychosocial Formulation and Use Diagnostic Reasoning and Clinical Decision Making That Involve the Family Alison Heru, M.D.
Different Models of Family Intervention and Their Application to Psychiatric Disorders, Symptoms, and Situations Ira Glick, M.D.
S39. Harm Reduction and Prevention of Stalking
Stalking of Health Care Professionals: Reducing the Risk Gail E. Robinson, M.D.
Treatment of Stalkers Werner Tschan, M.D.
Stalking Behavior Among Juveniles: Opportunities for Early Intervention Rosemary Purcell, Ph.D.
Assessment and Management of Stalking and Threatening Activity in Campus Settings Mario Scalora, Ph.D.
S40. Evidence-Based Outcomes in Psychiatry: Updates on Measurement Using Patient-Reported Outcomes (PRO) APA Task Force on DSM-5
Patient-Reported Outcome Measures in DSM-5 William Narrow, M.D., M.P.H.
Patient Reported Outcomes Measurement Information System (PROMIS): Overview and Applications for Mental Health Research William Riley, Ph.D.
Patient-Reported Outcome Measure in Clinical Trials—An FDA Perspective June Cai, M.D.
International Pilot Study on Patient-Reported Outcomes in Schizophrenia Massimo Moscarelli, M.D.
S41. Longitudinal Course and Outcome in Borderline Personality Disorder
Parental Viewpoints on Trajectories to the Development of Borderline Personality Disorder in Males Marianne Goodman, M.D.
Rates of Recurrence of the Symptoms of BPD after Sustained Symptomatic Remission Mary Zanarini, Ed.D.
Prospective Predictors of Suicide Attempts in Borderline Personality Disorder at Six-Year Follow-Up Paul Soloff, M.D.
Prospective Risk Factors for Suicide Attempts in a Treated Sample of Patients With Borderline Personality Disorder (BPD) Paul Links, M.D.
S42. Madness and the City: Facing De- and Re-Institutionalization in Western European Metropolises
Characteristics and Impact of De- and Re-Institutionalization in Western Europe Joséphine Caubel, M.D.
Cities as Creators of Madness Wilco Tuinebreijer, M.D.
Integrative Care: The Way From Hospital to Outpatient Settings in Germany Jürgen Gallinat, Ph.D., M.D.
Birmingham: An Integrated Model of Hospital and Community Mental Health Service Provision Mervyn Morris, M.A., Ed.D.
Assertive Community Treatment in Amsterdam: The Dutch Answer to Deinstitutionalization Jeroen Zoeteman, M.D.
S43. Placebo Effects in Psychiatry
The Psychology and Psychodynamics of the Placebo Response Javier Garcia, M.D.
Placebo Effect in Clinical Trials Intikhab Ahmad, M.D.
Ethical Dilemmas in the Use of Placebo Joel Idowu, M.D.
The Neurobiology of Placebo Effects William Head, M.D.
The Placebo Effects in Clinical Practice Sheldon Blackman, Ph.D.
9 a.m.-10:30 a.m.
Scientific and Clinical Reports
SCR 20. Miscellaneous Topics/Diagnostic Issues
67. Visualizing Mental Diseases: Distinct Plasma Levels of Cytokines and Chamokines in Schizophrenia and Major Depressive Disorder Sekiyama Atsuo, M.D., Ph.D.
68. Conversion Disorder Presenting as Hemiplegia in a Patient With Familial Hemiplegic Migraine George Paris, M.D.
69. Diagnostic Stability in Major Depressive Disorder With Versus Without Psychotic Features John Goethe, M.D.
Workshops
W61. Guardianship and Advance Directives in Psychiatry Chair: Renée M. Sorrentino, M.D.
W62. Behavioral Addictions: New Category in DSM-5 Chairs: Ken Rosenberg, M.D., Charles O'Brien, M.D., Ph.D.
W63. Gender-Specific Neurobiological, Behavioral, and Social Influence on Human Development: Implications for Heterosexual Relationships and Couples Therapy Chair: Scott D. Haltzman, M.D.
W64. Examining the Social Determinants of Mental Health Among Various Racial/Ethnic Populations Chairs: Ruth S. Shim, M.D., M.P.H., Monica Taylor-Desir, M.D., M.P.H.
W65. Making the Most of Your Chief Year: Chief Residents' Forum II Chair: Jonathan Amiel, M.D. (Open to residents only)
W66. Professional Transitions: The PGY-4 Journey Through Terminations and Graduation to "Real Life" Chair: Joan M. Anzia, M.D.
W67. NIMH Psychopharmacology Trials: How the Results Inform Practice Chair: Adelaide S. Robb, M.D.
10 a.m.-11:30 a.m.
Advances in Medicine
AM2. Update on Epilepsy: The Diagnosis and Management of Patients With "Spells" Chair: Alan G. Stein, M.D.
Focus Live 2
Substance Abuse Chair: Marc Galanter, M.D.
New Research Poster Session 6
Lectures
L14. Disease Biomarkers for Schizophrenia: From Laboratory to Patient Bedside Chair: Sabine Bahn, M.D.
L15. The Alienist in the 21st Century Chair: Dinesh Bhugra, M.B.B.S., Ph.D.
L16. 30 Years' Experiences in Providing Mental Health Care to Asian Refugees and Immigrants Chair: Paul Leung, M.D.
L17. Transforming Clinical Outcomes in Addiction Chair: Nora D. Volkow, M.D.
Small Interactive Sessions
SI06. Child Psychopharmacology: Current Controversies Chair: Barbara J. Coffey, M.D., M.S.
SI07. Top 10 Geriatric Psychiatry Issues for the General Psychiatrist Chair: Josepha A. Cheong, M.D.
Workshops
W68. Does the Brain Ever Recover From Drug Addiction? National Institute on Drug Abuse; Chair: Steven Grant, Ph.D.
W69. Computer-Assisted Cognitive Behavioral Therapy (CCBT): Practical Implications for Everyday Practice Chairs: Jesse H. Wright, M.D., Amanda B. Mackey, M.D., Sarah B. Johnson, M.D., M.Sc.
W70. Challenges in Treating and Evaluating Physicians Chair: Glen O. Gabbard, M.D.
11:30 a.m.-3:30 p.m.
Courses 30-35
New Research Poster Session 6
Seminars
SM9. Overview of Recovery for Psychiatrists Chair: Mark Ragins, M.D.
SM10. Practical Guide to the Performance of the Mental Status Examination Chair: Stephen I. Deutsch, M.D., Ph.D.
Noon-1:30 p.m.
Case Conference
CC3. Evaluating and Treating the Psychological Effects of War Chairs: Elspeth C. Ritchie, M.D., Marvin Oleshansky, M.D.
Forum
F5. Health Reform: Transforming Addiction Services in the United States National Institute on Drug Abuse; Chairs: Wilson M. Compton, M.D., Nora D. Volkow, M.D.
Lecture
L19. Alexandra Symonds Award Lecture (moved to IPS meeting)
L19. Stress, Cortisol, and Psychosis in Depression Chair: Alan F. Schatzberg, M.D.
Media Workshop
MW6. "Out in the Silence": A Film About Being Gay or Lesbian in Small-Town America American Academy of Child and Adolescent Psychiatry; Chair: Richard R. Pleak, M.D.
Scientific and Clinical Reports
SCR 21. Psychopharmacology 2
70. Bruxism and Antidepressants Harvinder Singh, M.D.
71. Rapid Response of Disabling Tardive Dyskinesia to a Short Course of Amantadine Gaurav Jain, M.D.
72. Current Prescribing Practices: Antipsychotic Polypharmacy in Patients With Schizophrenia and Schizoaffective Disorder John Bonetti, D.O.
73. Prescription Rates of Selective Serotonin Reuptake Inhibitors (SSRIs) After Introduction of Generic Equivalents: A Population-Based Study James Bolton, M.D.
SCR 22. Schizophrenia and Other Psychotic Disorders 2
74. Parsing the Heterogeneity of Schizophrenia: The Utility of Four Early-Course Features in Subtyping First-Episode Nonaffective Psychosis Michael Compton, M.D., M.P.H.
75. Mood Symptoms in Patients Presenting With Primary Psychosis After Age 40: A Prospective Cohort Study Rebecca Anglin, M.D.
76. A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk Thomas Stroup, M.D., M.P.H.
77. Meta-analysis of Phase 3 Trials of Iloperidone in the Short-Term Treatment of Schizophrenia: Efficacy Outcomes Based on Pretreatment Status Stephen Stahl, M.D., Ph.D.
Small Interactive Sessions
SI08. Successful Cognitive and Emotional Aging: How Can We Get There? Chair: Dilip V. Jeste, M.D.
SI09. Management of Anxiety and Depression in the Medically Ill Chair: Catherine C. Crone, M.D.
Workshops
W71. Diagnostic Assessment in DSM-5: Approaches and Examples American Psychiatric Institute for Research and Education; Chairs: David J. Kupfer, M.D., Darrel A. Regier, M.D.
W72. Mental Health Issues and the Law of Deportation APA Council on Psychiatry and Law; Chair: Patricia R. Recupero, J.D., M.D.
W73. Primary Care Behavioral Health Integration: Roles of the Key Team Members Chair: Lori Raney, M.D.
W74. The Older Adult Driver With Dementia: Safety Concerns and Physician Interventions APA Council on Adult Psychiatry; Chair: Helen H. Kyomen, M.D., M.S.
W75. Models for Ma ximizing Clinical Revenues and Supporting the Academic Mission: A Joint Presentation of the AACDP and AAP Chairs: Paul Summergrad, M.D., Radmila Bogdanich, M.A.
W76. Going International: Improving International Medical Graduates' Training Experiences During Psychiatry Residency Chair: Sanjeev Sockalingam, M.D.
W77. What Have You Done for Me Lately: Identifying Early Career Psychiatrists' Needs and Resources Within the APA Membership Committee Chair: Nioaka N. Campbell, M.D.
Noon-3 p.m.
Advances in Series
A3. Advances in Psychotherapy Chair: Glen O. Gabbard, M.D.
1. Psychotherapies for Hyperarousal and Dissociative Subtypes of PTSD: Similarities and Differences David Spiegel, M.D.
3. Psychotherapy With Suicidal Patients Barbara H. Stanley, Ph.D.
4. Psychotherapy Plus: Medication for Addictive Disorders Charles O'Brien, M.D., Ph.D.
5. Psychotherapy Induces Proliferation of Brain Serotonin 5-HT1A Receptors but Does Not Influence Dopamine D2/3 Receptors in Patients With Major Depressive Disorder Hasse Karlsson, M.D., Ph.D.
Presidential Symposium 4
PS4. Translating Neuroscience for Advancing Treatment and Prevention of Posttraumatic Stress Disorder Chair: Charles Marmar, M.D.
Reconsolidation Blockade as a Novel Strategy for Treating PTSD Charles Marmar, M.D.
Targeting Peptides for Novel Pharmacological Treatments of PTSD Thomas Neylan, M.D.
Neuroscience Informed Strategies for Early Intervention for PTSD Arieh Y. Shalev, M.D.
Interrupting the Intergenerational Transmission of Trauma by Treating Maternal PTSD and Optimizing Maternal Care Claude M. Chemtob, Ph.D.
Symposia
S44. Comprehensive HIV Psychiatry Update
HIV/AIDS Medical Update The Very Right Rev. Drew A. Kovach, M.D., M.Div.
Neuropsychiatric Overview Marshall Forstein, M.D.
Neurocognitive Decline Karl Goodkin, M.D., Ph.D.
Psychopharmacology Stephen Ferrando, M.D.
S45. Research Update: New Developments in the Treatment of Mood Disorders National Institute of Mental Health
New Insight Into the Neurobiology of Depression and the Development of Rapid-Acting Antidepressants and Biomarkers of Response Carlos Zarate, M.D.
Combining Medications to Enhance Depression Outcomes (CO-MED) Madhukar Trivedi, M.D.
TMS, Magnetic Seizure Therapy in Animals Holly Lisanby, M.D.
The NIMH Bipolar Trials Network Lithium Treatment Moderate Dose Use Study (LiTMUS): A Randomized, Comparative Effectiveness Trial of Adjunctive Lithium Joseph Calabrese, M.D.
S46. Recovery: Practical and Policy Lessons From Around the World
The Experience of Soul/Atman/Center/Hara/Seika Tanden/Spirit as an Essential Element of Being Necessary for Flourishing to Progress to Recovery Carl C. Bell, M.D.
The Impact of Health Reform on the Recovery Movement in America Steven Sharfstein, M.D., M.P.A.
Recovery: Practical and Policy Lessons From Around the World Jair Mari, M.D.
Recovery, Psychiatry, and Federal Mental Health Policy in the U.S. Kenneth Thompson, M.D.
S47. Treatment-Resistant Depression: A Roadmap for Effective Care
Treatment-Resistant Depression: Overview of the University of Michigan Depression Center Roadmap John F. Greden, M.D.
Psychopharmacological Roadmap for Treatment-Resistant Depression Srijan Sen, M.D.
Treatment-Resistant Depression Among Adolescents Neera Ghaziuddin, M.D.
Treatment-Resistant Depression: A Roadmap for Effective Care Michelle B. Riba, M.D.
Device-Related Neuromodulation in Treatment-Resistant Depression Daniel Maixner, M.D.
S48. Psychiatric Malpractice: Maintaining Solid Footing on Shaky Ground
Important Clinical and Legal Concepts Pertaining to Psychiatric Malpractice Craig Beach, M.D., M.Sc.
Cases to Illustrate Practical Strategies to Minimize Malpractice Risk and Navigate the Legal System in the Event of a Lawsuit Praveen Kambam, M.D.
What Really Occurs During a Malpractice Action Louis DelSignore, J.D.
Potential Emotional, Ethical, and Practical Implications of Being Sued Carolyn Wolf, J.D., M.S.
S49. Challenges and Conflicts in Professional Leadership at Psychiatric Institutions
Challenges and Conflicts in Professional Leadership at Psychiatric Institutions Robert Michels, M.D.
The Evolving Clinical-Administrative Function Richard Munich, M.D.
S50. Neural Correlates of Rapid Eye Movement (REM) and Dreaming: Implications for Dream Theory
Human Genotypic and Phenotypic Adaptations to Their Environments Jimmie Harris, D.O.
fMRI Evidence for Multisensory Recruitment Associated With Rapid Eye Movements During Sleep Charles Chong-Hwa Hong, M.D., Ph.D.
Imaging Correlates of Lucid Dreaming Renate Wehrle, Ph.D.
Quantitative EEG Correlates of Lucid Dreaming Ursula Voss, Ph.D.
S51. Bipolar Disorder: Controversies in Epidemiology and Treatment in Children and Adults in the U.S. and France: Vive la Difference!
More Childhood-Onset Bipolar Illness in the U.S. Than in Europe Robert Post, M.D.
Bipolar Disorder: Under- or Overdiagnosed Jean Michel Azorin, M.D.
Bipolar Disorder in Youth: Controversies in the U.S. and Abroad Robert Hendren, D.O.
Treatment Recommendations: The French Experience Philippe Courtet, M.D., Ph.D.
Prevalence and Characteristics of Bipolar Disorders in Patients With a Major Depressive Episode Charles Bowden, M.D.
The Challenge of Bipolar Depression Diagnosis and Treatment François Petitjean, M.D.
S52. Psychiatric and Behavioral Genetics: Ethical and Legal Challenges
Psychiatric and Behavioral Genetics and the Eugenic Legacy Paul S. Appelbaum, M.D.
Prenatal Genetic Screening for Psychiatric Disorders and Behavioral Traits Mildred Cho, Ph.D.
Newborn Genetic Screening: Legal and Ethical Concerns Steven Hoge, M.D., M.B.A.
Is Epigenetics a New Paradigm for Understanding Behavior? Nancy Press, Ph.D.
Ethical Issues in Psychopharmacogenetic Testing Jinger Hoop, M.D.
S53. What's the Difference That Makes the Difference? Commonalities and Differences Across Efficacious Treatments for BPD
Mentalization Based Treatment (MBT) and its Relationship to Other Psychotherapies for Borderline Personality Disorder Anthony Bateman, M.D.
Transference-Focused Psychotherapy: The Relationship in the Here-and-Now as the Key Frank Yeomans, M.D., Ph.D.
Dialectical Behavior Therapy Linda Dimeff, Ph.D.
TARA DBT-MBT Family Training Valerie Porr, M.A.
S54. Predictors, Moderators, and Mediators in Major Depressive Disorder
Predictors, Moderators, and Mediators of Symptom Improvement in Major Depressive Disorder: Focus on Clinical Factors George Papakostas, M.D.
Pharmacogenomics of Major Depression Julio Licinio, M.D.
Phosphorus-31 MRS Studies of High Energy Phosphates in MDD: Implications for Treatment Response and Novel Therapies Perry Renshaw, M.D., Ph.D.
Neurophysiologic Biomarkers for Predicting Treatment Outcome in MDD Andrew Leuchter, M.D.
S55. The Use of QEEG for Psychiatric Treatment Biomarkers
ATR-A QEEG-Based Biomarker of Treatment Response in Major Depression Dan Iosifescu, M.D., M.Sc.
Referenced-EEG (rEEG) Daniel Hoffman, M.D.
iSPOT Evian Gordon, Ph.D.
S56. Advances on Suicide Prevention: Preventing the Predictable
Personality and Life Events as Predictive Factors of Suicidal Behavior Hilario Blasco-Fontecilla, M.D., Ph.D.
Predictive Models in Suicidal Behavior Jorge Lopez-Castroman, M.D., Ph.D.
Novel Classification Tools for Suicide Prediction Fernando Perez-Cruz, B.Sc.
Data Mining, Suicide, and More: Our Experience M. Mercedes Perez-Rodriguez, M.D., Ph.D.
Implementation of All These Novel Tools in the Prevention of Suicide Jose de Leon, M.D.
S57. Collaborative Strategies Between Psychiatrists and Judges to Improve Outcomes for Defendants With Mental Illnesses
Overview of Topic Fred C. Osher, M.D.
The Judge's Role Steven Leifman, J.D.
Collaborative Strategies Between Psychiatrists and Judges to Improve Outcomes for Defendants With Mental Illnesses Annelle Primm, M.D., M.P.H.
How the Issue Impacts Hawaiians Marcia Waldorf, J.D.
1 p.m.-3 p.m.
New Research Poster Session 7
3:30 p.m.-5 p.m.
Convocation of Distinguished Fellows Archbishop Desmond Tutu, William C. Menninger Memorial Lecture
Information & Authors
Information
Published In
History
Published online: 18 February 2011
Published in print: February 18, 2011
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
PDF/ePub
View PDF/ePubGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).